These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31094778)

  • 1. Attenuation of Unevoked Mechanical and Cold Pain Hypersensitivities Associated With Experimental Neuropathy in Mice by Angiotensin II Type-2 Receptor Antagonism.
    Shepherd AJ; Mohapatra DP
    Anesth Analg; 2019 Jun; 128(6):e84-e87. PubMed ID: 31094778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain.
    Shepherd AJ; Copits BA; Mickle AD; Karlsson P; Kadunganattil S; Haroutounian S; Tadinada SM; de Kloet AD; Valtcheva MV; McIlvried LA; Sheahan TD; Jain S; Ray PR; Usachev YM; Dussor G; Krause EG; Price TJ; Gereau RW; Mohapatra DP
    J Neurosci; 2018 Aug; 38(32):7032-7057. PubMed ID: 29976627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule angiotensin II type 2 receptor (AT₂R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia.
    Smith MT; Woodruff TM; Wyse BD; Muralidharan A; Walther T
    Pain Med; 2013 Oct; 14(10):1557-68. PubMed ID: 23742186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation.
    Bessaguet F; Danigo A; Magy L; Sturtz F; Desmoulière A; Demiot C
    Neuropharmacology; 2017 Nov; 126():142-150. PubMed ID: 28882562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain.
    Muralidharan A; Wyse BD; Smith MT
    Pain Med; 2014 Jan; 15(1):93-110. PubMed ID: 24433468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin type 2 receptor antagonism as a new target to manage gout.
    Vieira TN; Saraiva ALL; Guimarães RM; Luiz JPM; Pinto LG; de Melo Rodrigues Ávila V; Goulart LR; Cunha-Junior JP; McNaughton PA; Cunha TM; Ferreira J; Silva CR
    Inflammopharmacology; 2022 Dec; 30(6):2399-2410. PubMed ID: 36173505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies.
    Anand U; Yiangou Y; Sinisi M; Fox M; MacQuillan A; Quick T; Korchev YE; Bountra C; McCarthy T; Anand P
    Mol Pain; 2015 Jun; 11():38. PubMed ID: 26111701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage angiotensin II type 2 receptor triggers neuropathic pain.
    Shepherd AJ; Mickle AD; Golden JP; Mack MR; Halabi CM; de Kloet AD; Samineni VK; Kim BS; Krause EG; Gereau RW; Mohapatra DP
    Proc Natl Acad Sci U S A; 2018 Aug; 115(34):E8057-E8066. PubMed ID: 30082378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy.
    Smith MT; Lau T; Wallace VC; Wyse BD; Rice AS
    Behav Pharmacol; 2014 Apr; 25(2):137-46. PubMed ID: 24525712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice.
    Muñoz MC; Burghi V; Miquet JG; Cervino IA; Quiroga DT; Mazziotta L; Dominici FP
    Peptides; 2017 Feb; 88():37-45. PubMed ID: 27979738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of angiotensin II type 2 receptor stimulation in vincristine-induced mechanical allodynia.
    Bessaguet F; Danigo A; Bouchenaki H; Duchesne M; Magy L; Richard L; Sturtz F; Desmoulière A; Demiot C
    Pain; 2018 Dec; 159(12):2538-2546. PubMed ID: 30086116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Immunol; 2020; 11():615327. PubMed ID: 33408720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin II-infused renal injury mice.
    Zhu Y; Cui H; Lv J; Liang H; Zheng Y; Wang S; Wang M; Wang H; Ye F
    Sci Rep; 2019 Dec; 9(1):19450. PubMed ID: 31857626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan, an Angiotensin II Type 1 Receptor Antagonist, Alleviates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain by Inhibiting Inflammatory Cytokines in the Dorsal Root Ganglia.
    Kim E; Hwang SH; Kim HK; Abdi S; Kim HK
    Mol Neurobiol; 2019 Nov; 56(11):7408-7419. PubMed ID: 31037647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
    Bogacka J; Popiolek-Barczyk K; Pawlik K; Ciechanowska A; Makuch W; Rojewska E; Dobrogowski J; Przeklasa-Muszynska A; Mika J
    Eur J Pharmacol; 2020 Aug; 880():173166. PubMed ID: 32407723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain.
    Smith MT; Muralidharan A
    Expert Opin Ther Targets; 2015 Jan; 19(1):25-35. PubMed ID: 25315162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antioxidant N-(2-mercaptopropionyl)-glycine (tiopronin) attenuates expression of neuropathic allodynia and hyperalgesia.
    Shahid M; Subhan F; Islam NU; Ahmad N; Farooq U; Abbas S; Akbar S; Ullah I; Raziq N; Din ZU
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):603-617. PubMed ID: 33079239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 2-receptor: new clinically validated target in the treatment of neuropathic pain.
    Rice AS; Smith MT
    Clin Pharmacol Ther; 2015 Feb; 97(2):128-30. PubMed ID: 25670516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin 4 receptor induces hyperalgesia and allodynia after chronic constriction injury by activation of p38 MAPK in DRG.
    Chu H; Xia J; Yang Z; Gao J
    Int J Neurosci; 2012 Feb; 122(2):74-81. PubMed ID: 21985621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors.
    Zhao X; Li XL; Liu X; Wang C; Zhou DS; Ma Q; Zhou WH; Hu ZY
    Pharmacol Res; 2015 Dec; 102():286-97. PubMed ID: 26520392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.